Pharmafile Logo
Pharmafocus logo
Advanced Search

Payment changes of authority’s fees in France

January 20, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates, regulatory affairs

Changes are being made in the way fees are paid for regulatory submissions and procedures in France.  Fees are no …

News
Press release

Novartis’ Signifor recommended in Europe

January 20, 2012
Research and Development, Sales and Marketing CHMP, Cushing's disease, Novartis, Signifor

A European committee has recommended Novartis’ Signifor for the treatment of a rare, debilitating endocrine disorder. The European Committee for …

News
Gilenya image

EMA to review safety of MS drug Gilenya

January 20, 2012
Research and Development, Sales and Marketing CHMP, EMA, Novartis, gilenya

The European Medicines Agency has begun a review into the safety of Novartis’ multiple sclerosis drug Gilenya. This follows concerns …

News

British pharmacy to sell ‘smart pills’

January 20, 2012
Sales and Marketing Lloyds pharmacy, Proteus Biomedical, smart pill

Proteus Biomedical has teamed up with Lloydspharmacy to sell Helius, a smart pill that tells a patient when to take …

News

AZ and BMS diabetes drug needs more data

January 20, 2012
Research and Development, Sales and Marketing AstraZeneca, BMS, FDA approvals, diabetes

AstraZeneca and Bristol-Myers Squibb must supply more data on their diabetes treatment dapagliflozin, the FDA says.Currently being developed as monotherapy, …

News

Novartis starts late-stage biosimilar trials for Amgen drugs

January 19, 2012
Research and Development, Sales and Marketing Amgen, Neulasta, Neupogen, Novartis

Novartis has begun Phase III biosimilar trials to copycat two of Amgen’s neutropenia drugs. The studies, which are being undertaken …

News

Chief operating officer appointed to Clinigen’s services division

January 19, 2012
Business Services, Medical Communications, Research and Development, Sales and Marketing Clinigen, Shaun Chilton

Clinigen Group, a global specialty pharma services and products business, has appointed Shaun Chilton as its new chief operating officer …

Appointment
Takeda image

Takeda to cut 2,800 jobs

January 19, 2012
Business Services, Research and Development, Sales and Marketing Nycomed, Takeda, job cuts

Takeda has announced plans to significantly reduce its global headcount over the next four years following its merger with Nycomed. …

News
mike_crooks_web

Astellas Pharma Europe appoints Mike Crooks to head up its UK operations

January 19, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, Mike Crooks

Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma, has appointed Mike Crooks as its new UK general manager. …

Appointment

Nurses come out against Health Bill

January 19, 2012
Sales and Marketing NHS, RCN, health bill, reforms

The union representing nurses and midwives in the UK has formally come out against the government’s health reform Bill.  The …

News
Bayer image

Bayer’s colorectal cancer drug increases survival

January 19, 2012
Research and Development, Sales and Marketing Bayer, colectoral cancer, regorafenib

Bayer and Onyx’s colorectal cancer drug regorafenib increased overall survival for late-stage patients, according to new data. The Phase III …

News
Lucentis image

Lucentis approved in China

January 18, 2012
Sales and Marketing China, Galvus, Lucentis, Novartis, em, emerging markets

Novartis’ eye treatment Lucentis has gained approval in China, and the firm has also launched its diabetes drug Galvus in …

News

Lundbeck gets award for manufacturing excellence

January 18, 2012
Manufacturing and Production Lundbeck, Shingo, manufacturing

Efforts by Lundbeck to boost the productivity of its manufacturing operations have borne fruit, with the company cutting costs by …

News

Former Bristol-Myers Squibb man becomes head of Savient Europe

January 18, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Savient

Savient Pharmaceuticals has appointed David Veitch as the new president of its European division. Veitch joins the specialist biopharma firm …

Appointment
Pfizer image

Pfizer pulls plug on Alzheimer’s drug

January 18, 2012
Research and Development, Sales and Marketing Medivation, Pfizer, dimebon

Pfizer and Medivation have written off their Alzheimer’s candidate dimebon after another Phase III failure.  The firms said a 12-month …

News

Countdown to PM Society Advertising Awards begins

January 18, 2012
Medical Communications, Sales and Marketing PM Society Advertising Awards, pm society

The Pharmaceutical Marketing Society’s Advertising Awards, one of the most significant dates in the UK pharma industry calendar, are approaching …

News
Novartis image

Novartis reverses plant closure decision

January 18, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Basel, Diovan, Novartis, Nyon, closure, job cuts

Novartis has said it will not close down a plant in Switzerland that had been due for closure, and has …

News
Tamiflu image

BMJ blasts Roche for withholding Tamiflu data

January 18, 2012
Research and Development, Sales and Marketing BMJ, EMA, Roche, Tamiflu, WHO

Roche is still withholding Tamiflu data from researchers, claims the British Medical Journal. Two years after Roche said it would …

News

The work of NICE International

January 17, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kalipso Chalkidou, NICE

NICE, or the National Institute for Health and Clinical Excellence, to give it its full title, is world famous for …

Feature

CoreLab Partners opens office in Tokyo, Japan

January 17, 2012
Research and Development

Princeton, NJ January 17, 2012 – Signaling a further commitment to expand its business model in the Pacific Rim and …

News
Press release
The Gateway to Local Adoption Series

Latest content

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026